These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11302599)

  • 41. Nucleic acid testing and tissue safety: an eye bank's five-year review of HIV and hepatitis testing for donor corneas.
    Heck E; Brown A; Cavanagh HD
    Cornea; 2013 Apr; 32(4):503-5. PubMed ID: 23023406
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical application and viability of cryopreserved cadaveric skin allografts in severe burn: a retrospective analysis.
    Cleland H; Wasiak J; Dobson H; Paul M; Pratt G; Paul E; Herson M; Akbarzadeh S
    Burns; 2014 Feb; 40(1):61-6. PubMed ID: 24018216
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of renal allografts from donors positive for hepatitis B core antibody confers minimal risk for subsequent development of clinical hepatitis B virus disease.
    Madayag RM; Johnson LB; Bartlett ST; Schweitzer EJ; Constantine NT; McCarter RJ; Kuo PC; Keay S; Oldach DW
    Transplantation; 1997 Dec; 64(12):1781-6. PubMed ID: 9422420
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Screening for hepatitis B virus DNA in serum of organ donors and renal transplant recipients.
    Miédougé M; Rostaing L; Mansuy JM; Sandres-Sauné K; Boudet F; Izopet J
    Eur J Clin Microbiol Infect Dis; 2003 Apr; 22(4):246-8. PubMed ID: 12709839
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatitis B virus blood screening: unfinished agendas.
    Comanor L; Holland P
    Vox Sang; 2006 Jul; 91(1):1-12. PubMed ID: 16756595
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Variables determining the amount of microbial contamination on cadaveric allograft skin used as a biological wound dressing.
    May SR; Wainwright JF; DeClement FA
    Burns Incl Therm Inj; 1985 Apr; 11(4):242-51. PubMed ID: 3891023
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Donor screening for hepatitis B virus infection in a cell and tissue bank.
    Solves P; Mirabet V; Alvarez M; Vila E; Quiles F; Villalba JV; Montoro JA; Soler MA; Roig RJ
    Transpl Infect Dis; 2008 Dec; 10(6):391-5. PubMed ID: 18665905
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New technologies for infectious screening of organ donors.
    Fishman JA
    Transplant Proc; 2011; 43(6):2443-5. PubMed ID: 21839288
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors.
    Prakoso E; Strasser SI; Koorey DJ; Verran D; McCaughan GW
    Clin Transplant; 2006; 20(3):369-73. PubMed ID: 16824156
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Microbiological evaluation of glycerolized cadaveric donor skin.
    van Baare J; Ligtvoet EE; Middelkoop E
    Transplantation; 1998 Apr; 65(7):966-70. PubMed ID: 9565102
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The use of human deceased donor skin allograft in burn care.
    Leon-Villapalos J; Eldardiri M; Dziewulski P
    Cell Tissue Bank; 2010 Feb; 11(1):99-104. PubMed ID: 20077178
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Testing of corneoscleral discs and their culture media of seropositive donors for hepatitis B and C virus genomes.
    Sengler U; Reinhard T; Adams O; Gerlich W; Sundmacher R
    Graefes Arch Clin Exp Ophthalmol; 2001 Oct; 239(10):783-7. PubMed ID: 11760041
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of HBsAg-positivity of kidney donors on long-term patient and graft outcome.
    Berber I; Aydin C; Yigit B; Turkmen F; Titiz IM; Altaca G
    Transplant Proc; 2005 Dec; 37(10):4173-5. PubMed ID: 16387070
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of nucleic acid testing in cadaver organ donor screening: detection of hepatitis C virus RNA in seropositive and seronegative donors.
    Aswad S; Khan NS; Comanor L; Chinchilla C; Corado L; Mone T; Mendez R; Mendez R
    J Viral Hepat; 2005 Nov; 12(6):627-34. PubMed ID: 16255764
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection of hepatitis C virus infection among cadaver organ donors: evidence for low transmission of disease.
    Roth D; Fernandez JA; Babischkin S; De Mattos A; Buck BE; Quan S; Olson L; Burke GW; Nery JR; Esquenazi V
    Ann Intern Med; 1992 Sep; 117(6):470-5. PubMed ID: 1323944
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A controlled study of hepatitis C transmission by organ transplantation. The New England Organ Bank Hepatitis C Study Group.
    Pereira BJ; Wright TL; Schmid CH; Levey AS
    Lancet; 1995 Feb; 345(8948):484-7. PubMed ID: 7532254
    [TBL] [Abstract][Full Text] [Related]  

  • 57. How to improve donor skin availability: Pragmatic procedures to minimize the discard rate of cryopreserved allografts in skin banking.
    Germain N; Hatzfeld AS; Pasquesoone L; Danze PM; Guerreschi P; Sendid B; Gaillot O; Marchetti P
    Burns; 2021 Mar; 47(2):387-396. PubMed ID: 32788056
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Infectious disease markers in blood donors in northern Thailand.
    Mundee Y; Kamtorn N; Chaiyaphruk S; Nantachit N; Ness PM; Nelson KE
    Transfusion; 1995 Mar; 35(3):264-7. PubMed ID: 7878721
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessment of cryopreserved donor skin viability: the experience of the regional tissue bank of Siena.
    Pianigiani E; Tognetti L; Ierardi F; Mariotti G; Rubegni P; Cevenini G; Perotti R; Fimiani M
    Cell Tissue Bank; 2016 Jun; 17(2):241-53. PubMed ID: 26939692
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sexual transmission of hepatitis B in Mwanza, Tanzania.
    Jacobs B; Mayaud P; Changalucha J; Todd J; Ka-Gina G; Grosskurth H; Berege ZA
    Sex Transm Dis; 1997 Mar; 24(3):121-6. PubMed ID: 9132977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.